Impact of Brief Nicotine Messaging on Nicotine-Related Beliefs in a U.S. Sample.


Journal

American journal of preventive medicine
ISSN: 1873-2607
Titre abrégé: Am J Prev Med
Pays: Netherlands
ID NLM: 8704773

Informations de publication

Date de publication:
10 2019
Historique:
received: 03 01 2019
revised: 23 05 2019
accepted: 24 05 2019
entrez: 23 9 2019
pubmed: 23 9 2019
medline: 26 9 2020
Statut: ppublish

Résumé

The current study pilot tested the effect of a single, brief exposure to nicotine education messages on beliefs about nicotine, nicotine-replacement therapy (NRT), E-cigarettes, and cigarettes with reduced nicotine content (RNC). Five hundred and twenty-one U.S. adults (aged ≥18 years) completed a 15-minute survey on Amazon Mechanical Turk in 2018. After completing items on sociodemographics, literacy, and cancer risk behaviors, participants were randomized in a 2:1:1 ratio to 1 of 3 conditions: nicotine education (n=263), sun safety education (attention control, n=128), or no message control (n=130). All participants completed items regarding nicotine, NRT, E-cigarette, and RNC cigarette beliefs, as well as norms about nicotine use, behavioral control regarding cigarette/tobacco use, and intention to use cigarettes, NRT, E-cigarettes, and RNC cigarettes in the next 12 months. Analyses were conducted in 2019. Following exposure, nicotine education participants reported fewer false beliefs about nicotine (p<0.001), NRT (p<0.001), E-cigarettes (p<0.05), and RNC cigarettes (p<0.05) compared with the control conditions. Nicotine messaging doubled the probability of a correct response (false, 78.3% vs 36.8%) to nicotine is a cause of cancer and dramatically reduced the probability of responding don't know to this item (5.3% vs 26.0%). There was no impact of the intervention on beliefs about other substances within cigarette, norms, or behavioral intentions. Findings from the current study support the hypothesis that a brief nicotine messaging intervention-similar to the messages likely to be seen on warning labels or in media campaigns-is likely to correct misperceptions of nicotine, NRT, E-cigarettes, and RNC cigarettes.

Identifiants

pubmed: 31542145
pii: S0749-3797(19)30255-7
doi: 10.1016/j.amepre.2019.05.015
pmc: PMC6756180
mid: NIHMS1539015
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e135-e142

Subventions

Organisme : NIDA NIH HHS
ID : U54 DA031659
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA229973
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM103644
Pays : United States
Organisme : NCI NIH HHS
ID : R03 CA212694
Pays : United States
Organisme : NIDA NIH HHS
ID : U54 DA036114
Pays : United States

Informations de copyright

Copyright © 2019 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

Références

Clin Pharmacol Ther. 2001 Mar;69(3):175-83
pubmed: 11240982
Nicotine Tob Res. 2004 Dec;6 Suppl 3:S303-10
pubmed: 15799593
Nicotine Tob Res. 2004 Dec;6 Suppl 3:S333-40
pubmed: 15799596
BMC Fam Pract. 2006 Mar 24;7:21
pubmed: 16563164
Nicotine Tob Res. 2007 Jun;9(6):653-61
pubmed: 17558822
IARC Monogr Eval Carcinog Risks Hum. 2007;89:1-592
pubmed: 18335640
Tob Control. 2008 Sep;17 Suppl 1:i32-8
pubmed: 18768457
Addiction. 2008 Aug;103(8):1371-8
pubmed: 18855827
Tob Induc Dis. 2010 Aug 13;8:9
pubmed: 20707898
Addict Behav. 2011 Jul;36(7):713-6
pubmed: 21371825
N Engl J Med. 2015 Oct;373(14):1340-9
pubmed: 26422724
Trends Cardiovasc Med. 2016 Aug;26(6):515-23
pubmed: 27079891
Prev Med. 2017 Mar;96:94-100
pubmed: 28034733
Drug Alcohol Depend. 2017 Apr 01;173:99-106
pubmed: 28214392
JAMA Psychiatry. 2017 Oct 1;74(10):1056-1064
pubmed: 28832876
Tob Control. 2018 Nov;27(6):712-714
pubmed: 29363610
Health Psychol. 1996 Sep;15(5):355-61
pubmed: 8891714

Auteurs

Andrea C Villanti (AC)

Vermont Center on Behavior and Health, Department of Psychiatry, University of Vermont Larner College of Medicine, Burlington, Vermont. Electronic address: avillant@uvm.edu.

Julia C West (JC)

Vermont Center on Behavior and Health, Department of Psychiatry, University of Vermont Larner College of Medicine, Burlington, Vermont.

Darren Mays (D)

Department of Oncology, Georgetown University Medical Center, Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Washington, District of Columbia.

Eric C Donny (EC)

Department of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina.

Joseph N Cappella (JN)

Annenberg School for Communication at the University of Pennsylvania, Philadelphia, Pennsylvania.

Andrew A Strasser (AA)

Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH